Dato' DrAdzuan Abdul Rahman GCEOTMC Life Sciences BerhadMalaysia

Dato’ Dr. Adzuan Abdul Rahman joined TMC Life Sciences Berhad as Group CEO in February 2025, and serves concurrently as Regional Senior Director of Thomson Medical Group. With over 20 years of experience in clinical practice, hospital management, and strategy, he has held leadership roles across Malaysia, Singapore, Hong Kong, and Southeast Asia, driving innovation and growth. Trained in the United Kingdom, he transitioned from medicine to corporate healthcare after earning an MBA from IMD Business School, Switzerland. He held senior roles at Parkway Laboratories Singapore, Parkway East Hospital Singapore, and Gleneagles Hospital Kuala Lumpur, and later served as Regional Managing Director and Executive Vice President at idsMED Group. Most recently, he co-founded Novotec Pte Ltd, which focuses on novel and innovative technologies, including the application of Generative AI in healthcare. He holds a Bachelor of Medicine, Surgery, and Obstetrics from Queen’s University Belfast (UK), an MBA from IMD Business School (Switzerland), and has completed executive education in Mergers & Acquisitions at Imperial College Business School (UK).